ClinicalTrials.Veeva

Menu

Chorioamnionitis and Proinflammatory S100A12

C

Catholic University of the Sacred Heart

Status

Completed

Conditions

Chorioamnionitis Affecting Fetus or Newborn

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Histologic chorioamnionitis (HCA) may lead to the fetal inflammatory response syndrome (FIRS) and increased levels of proinflammatory molecules.

Full description

Histologic chorioamnionitis (HCA) may lead to the fetal inflammatory response syndrome (FIRS). The aim of this pilot study was to evaluate S100A12, a marker of innate immune activation, in mothers with or without HCA and in their infants.

Concentrations of S100A12, Interleukin 6 (IL-6) and C-reactive protein (CRP) were evaluated in maternal, cord, and neonatal blood of very preterm infants. Histologic examinations of placentae and umbilical cords were performed.

Enrollment

69 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Preterm Birth

Exclusion criteria

Congenital Abnormalities

Trial design

69 participants in 2 patient groups

group 1
Description:
maternal chorioamnionitis
group 2
Description:
no maternal chorioamnionitis

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems